How to implement pre-emptive pharmacogenetic testing in the acute hospital setting.

IF 1.9 4区医学 Q3 PHARMACOLOGY & PHARMACY

Pharmacogenomics Pub Date : 2025-09-19 DOI:10.1080/14622416.2025.2560295

John Henry McDermott, Ali Shoaib, Jessica Keen, Charlotte Skitterall, Videha Sharma, William Gerard Newman

引用次数: 0

Abstract

Your hospital has decided to introduce a pharmacogenomics program. What do you need to do to realize this ambition? In this paper, we set out the elements that should be considered, including the team and resources required to establish a sustainable program. This will draw on experience from successful global pharmacogenomic programs and will highlight key interdependencies, opportunities and challenges.

查看原文本刊更多论文

如何在急性病医院实施先发制人的药物遗传学检测。

你们医院决定引进药物基因组学项目。你需要做些什么来实现这个抱负？在本文中，我们列出了应该考虑的因素，包括建立可持续发展计划所需的团队和资源。这将借鉴成功的全球药物基因组学项目的经验，并将强调关键的相互依赖性、机遇和挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacogenomics 医学-药学

CiteScore

3.40

自引率

9.50%

发文量

审稿时长

4-8 weeks

期刊介绍： Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.